MYELORX

MyeloRx is a biotechnology company that develops drugs for oncology and immune-related diseases based on the natural product triptolide. Importantly, triptolide and the plant from which it is extracted, Tripterygium Wilfordii Hook f, has been shown to be clinically active in acute leukemias as well as in immune-based diseases such as rheumatoid arthritis. MyeloRx has in-licensed a series of composition of matter patents covering proprietary analogs of the natural product.